Variation in the thrombin activatable fibrinolytic inhibitor (TAFI) modulation by heparin: Therapeutic implications.

M. Florian-Kujawski; J. Maddineni; D. Hoppensteadt; M.H.M. Janssen; M. Wilmer; R. Bick; O. Iqbal; M. Tobu; J. Fareed

Variation in the thrombin activatable fibrinolytic inhibitor (TAFI) modulation by heparin: Therapeutic implications.

M. Florian-Kujawski, J. Maddineni, D. Hoppensteadt, M.H.M. Janssen, M. Wilmer, R. Bick, O. Iqbal, M. Tobu, J. Fareed

Research output: Contribution to Journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	548a-548a
Journal	Blood
Volume	102
Issue number	11
Publication status	Published - 2003

Persistent URL (handle)

Persistent link

Cite this

@article{917accbcafd546f8aa807fc3e2f944ef,

title = "Variation in the thrombin activatable fibrinolytic inhibitor (TAFI) modulation by heparin: Therapeutic implications.",

author = "M. Florian-Kujawski and J. Maddineni and D. Hoppensteadt and M.H.M. Janssen and M. Wilmer and R. Bick and O. Iqbal and M. Tobu and J. Fareed",

year = "2003",

language = "English",

volume = "102",

pages = "548a--548a",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "11",

}

TY - JOUR

T1 - Variation in the thrombin activatable fibrinolytic inhibitor (TAFI) modulation by heparin: Therapeutic implications.

AU - Florian-Kujawski, M.

AU - Maddineni, J.

AU - Hoppensteadt, D.

AU - Janssen, M.H.M.

AU - Wilmer, M.

AU - Bick, R.

AU - Iqbal, O.

AU - Tobu, M.

AU - Fareed, J.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0006-4971

VL - 102

SP - 548a-548a

JO - Blood

JF - Blood

IS - 11

ER -